A drug that stops cancer treatments damaging ovaries could preserve patients鈥
fertility. Researchers at the Memorial Sloan-Kettering Cancer Center and
Massachusetts General Hospital injected a compound called
sphingosine-1-phosphate into the ovaries of mice. This prevented a lipid in the
membrane of an egg cell being converted into another lipid called ceramide and
starting a chain reaction that ends in cell suicide (Nature Medicine,
vol 6, p 1109). 鈥淚f they have stopped [cell death] and produced normal embryos
from the ovaries, this is fantastic,鈥 says Geraldine Hartshorne of the University of Warwick.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles